TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03436004

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Colonoscopy
Description: Patients undergoing screening colonoscopy

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Colonoscopy with specific device (Endocuff Vision)
Description: Patients undergoing screening colonoscopy using the Endocuff Vision device
Study: NCT01231373

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: injection of vehicle comparator
Study: NCT01457820

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allopurinol
Description: Stat dose Allopurinol 800mg, then 400mg BD for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allopurinol
Description: Stat dose Allopurinol 400mg, then 300mg BD for 5 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo, stat dose, then 5 days of matched placebo BD.
Study: NCT00881673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL38583 Ophthalmic Solution
Description: Topical ophthalmic

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Maxidex
Description: Topical ophthalmic

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: AL38583 Vehicle
Study: NCT02208531

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychosocial Stimulation and Nutritional Care
Description: Psychosocial Stimulation and Nutritional Care will be provided to malnourished children and their mothers every fortnight in the Community Clinics for one year.
Study: NCT04317404

Intervention type: DRUG
Intervention: 40 mg Triamcinolone acetonide
Description: Unilateral knee steroid injection

Intervention type: DRUG
Intervention: 40 mg Triamcinolone acetonide
Description: Unilateral knee steroid injection

Intervention type: DRUG
Intervention: 40 mg Triamcinolone acetonide
Description: Unilateral knee steroid injection
Study: NCT04746196

Intervention type: OTHER
Intervention: Serum galectin-3 concentration was measured.
Description: Serum galectin-3 concentration was measured using a commercial chemiluminescent microparticle immunoassay.
Study: NCT01759979

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laser and mechanical lithotripsy
Description: Patients will undergo cholangioscopy guided laser treatment in addition to treatment with mechanical lithotripsy using basket and balloon techniques.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical Lithotripsy
Description: Patients in the mechanical lithotripsy arm will undergo treatment only with basket and balloons to facilitate stone removal but not laser lithotripsy.
Study: NCT03401788

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belzutifan
Description: 120 mg once daily (three 40 mg oral tablets once daily).
Study: NCT02135809

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WallFlex Pancreatic Stent
Description: Temporary placement of the WallFlex Pancreatic Stent for treatment of refractory pancreatic duct strictures in patients with painful chronic pancreatitis. Stent will be removed after 3-6 months indwell.
Study: NCT03493685

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sparsentan
Description: Double-blind period: target dose of 800 mg daily; Open-label extension: target dose based on dosage from week 114 daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Irbesartan
Description: target dose of 300 mg daily
Study: NCT02513641

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hypoxico Altitude Training Systems
Description: Participants will sleep in a tent (which will fit his/her personal mattress) simulating an altitude of \~2,400 meters for 7-12 hours each night for a period of 14 days. Baseline testing measures will include a oral glucose tolerance test (OGTT) and body composition (iDXA). Post-treatment testing measures will include OGTT only.
Study: NCT03035214

Intervention type: DRUG
Group type: OTHER
Intervention: Dexamethasone (Steroids)
Description: Is to describe the use of integrated assessment of respiratory physiology using Targeted Neonatal Echocardiography, assessment of optimal Functional Residual Capacity and the tolerance of lung oxygen uptake at different oxygen levels, and hence early prediction of Bronchopulmonary Dysplasia and the underlying pathophysiology by periodic application of the oxygen tolerance test; which may help early targeted treatment of this common disease.
Study: NCT00153205

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: computerized physician order entry

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: computerized physician order entry
Study: NCT00569777

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: K-Lens (generic name not established) and Ketotifen
Description: combination drug-device product: contact lens (device) and anti-allergy drug

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Lens
Description: contact lens without drug
Study: NCT03304782

Intervention type: OTHER
Intervention: Fitbit activity tracker
Description: Wearable device that records the number of steps a person takes throughout the day

Intervention type: OTHER
Intervention: Fitbit activity tracker
Description: Wearable device that records the number of steps a person takes throughout the day
Study: NCT00004241

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tanespimycin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tanespimycin
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study: NCT03656263

Intervention type: DIAGNOSTIC_TEST
Intervention: Doppler assessment of portal vein flow
Description: Doppler assessment of portal vein flow using peri-operative trans-esophageal echography before and after cardiopulmonary bypass.
Study: NCT01853371

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wet cupping
Description: Wet cupping is the process of using a vacuum at different points on the body in order to gather the blood in that area. Then apply few superficial incisions (small, light scratches using a razor) on those areas, followed by repeating the vacuum on the same areas in order to remove 'harmful' blood which lies just beneath the surface of the skin. In this study, the wet cupping procedure was not done on certain days of the lunar month.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: According to Saudi Hypertension management guidelines, hypertension patients may require life style modification alone , especially for newly diagnosed cases, or my require life style modification and drug treatment. This will be decided by the treating team in the hospital.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment
Description: According to Saudi Hypertension management guidelines, hypertension patients may require life style modification alone , especially for newly diagnosed cases, or my require life style modification and drug treatment. This will be decided by the treating team in the hospital.
Study: NCT01616316

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: subfascial flap
Description: subfacial dissection to thyroid

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: subplatysmal flap
Description: subplatysmal approach to thyroid
Study: NCT04615312

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: a CDK4 / 6 inhibitor and a MEK inhibitor
Description: Participant will receive a CDK4 / 6 inhibitor and a MEK inhibitor treatment to determine the maximum tolerated dose
Study: NCT02798003

Intervention type: OTHER
Intervention: Functional magnetic resonance imaging (fMRI)
Description: The food-cue elicited response in the reward-circuitry of the brain will be assessed by using fMRI. This technique is based on different magnetic properties of oxygenated and deoxygenated blood. Increased neuronal activity causes an increase in blood flow. Thereby, neuronal activity is indirectly reflected by changes in blood oxygenation level-dependent (BOLD) contrast.

Intervention type: OTHER
Intervention: Functional magnetic resonance imaging (fMRI)
Description: The food-cue elicited response in the reward-circuitry of the brain will be assessed by using fMRI. This technique is based on different magnetic properties of oxygenated and deoxygenated blood. Increased neuronal activity causes an increase in blood flow. Thereby, neuronal activity is indirectly reflected by changes in blood oxygenation level-dependent (BOLD) contrast.

Intervention type: OTHER
Intervention: Functional magnetic resonance imaging (fMRI)
Description: The food-cue elicited response in the reward-circuitry of the brain will be assessed by using fMRI. This technique is based on different magnetic properties of oxygenated and deoxygenated blood. Increased neuronal activity causes an increase in blood flow. Thereby, neuronal activity is indirectly reflected by changes in blood oxygenation level-dependent (BOLD) contrast.

Intervention type: OTHER
Intervention: Functional magnetic resonance imaging (fMRI)
Description: The food-cue elicited response in the reward-circuitry of the brain will be assessed by using fMRI. This technique is based on different magnetic properties of oxygenated and deoxygenated blood. Increased neuronal activity causes an increase in blood flow. Thereby, neuronal activity is indirectly reflected by changes in blood oxygenation level-dependent (BOLD) contrast.
Study: NCT00657683

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Monovalent GBS-CRM glycoconjugate vaccine
Description: 1 dose of GBS conjugate vaccine

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 dose of placebo
Study: NCT02235688

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aldoxorubicin
Description: administered at 170 mg/m2 by intravenous infusion (IVI) on Day 1 every 21 days plus 900 mg/m2 gemcitabine on Days 1 and 8 every 21 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aldoxorubicin
Description: administered at 250 mg/m2 by intravenous infusion (IVI) on Day 1 every 21 days plus 900 mg/m2 gemcitabine on Days 1 and 8 every 21 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aldoxorubicin
Description: administered at 350 mg/m2 by intravenous infusion (IVI) on Day 1 every 21 days plus 900 mg/m2 gemcitabine on Days 1 and 8 every 21 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine
Study: NCT03557905

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RM 0.5
Description: Patients will receive recruitment maneuver (RM) followed by decremental PEEP titration 1min. after establishment of mechanical ventilation and after documented lung re-collapse.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RM 0.3
Description: The patient will be ventilated with volume control mode with tidal volume 6 ml/kg, PEEP 3 cmH2O, an inspiratory expiratory ratio of 1:1.5, respiratory rate 20-25 breaths per minute depending on the patient's age and FiO2 of 0.3.
Study: NCT00131885

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control (Placebo Herb)
Description: Placebo herb three times daily (ground cellulose) for 4-6 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: St. John's Wort
Description: St. John's Wort (Hypericum perforatum) orally or 4-6 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: St. John's Wort
Description: St. John's Wort (Hypericum perforatum) orally or 4-6 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: St. John's Wort
Description: St. John's Wort (Hypericum perforatum) orally or 4-6 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Levonorgestrel
Description: Levonorgestrel in a single oral dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel
Description: Levonorgestrel in a single oral dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel
Description: Levonorgestrel in a single oral dose

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel
Description: Levonorgestrel in a single oral dose
Study: NCT03186820

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Susceptibility Weighted Imaging as 3D SWAN sequence
Description: Susceptibility Weighted Imaging as 3D SWAN sequence
Study: NCT03334955

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian drilling
Description: A specially designed monopolar electrocautery probe was used to penetrate the ovarian capsule at 4 points, with the aid of a short burst of monopolar diathermy. The probe (which has a distal stainless steel needle measuring 10 mm in length and 2 mm in diameter) was applied to the surface of the ovary at a right angle to avoid slippage and to minimize surface damage. A monopolar coagulating current at a 40 W power setting was used. The needle was pushed through the ovarian capsule for about 4 mm depth into the ovarian tissue and electricity was activated for 4 seconds.
Study: NCT03734055

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer Mentoring
Description: Manualized peer mentorship program designed to provide modeling and reinforcement by peers (mentors) to other African American women with SLE (mentees) to encourage them to engage in activities that promote disease self-management.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Support Group
Description: Social support controls will participate in a lupus support group created for this project, on the same schedule as peer mentoring sessions.
Study: NCT02614248

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Organic, Unrefined Coconut Oil
Study: NCT03889093

Intervention type: OTHER
Group type: OTHER
Intervention: Yttrium-90
Description: This is to evaluate the immunologic effects of yttrium 90.
Study: NCT01925001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MP4CO
Description: 43 mg/mL pegylated carboxyhemoglobin \[≥ 90% CO hemoglobin saturation\] in physiological acetate electrolyte solution
Study: NCT02614248

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medline Remedy Phytoplex Z-Guard Skin Protectant
Study: NCT01586910

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical Aortic Valve Replacement (SAVR)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI)
Study: NCT04473196

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: weightbearing
Description: immediate weightbearing

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: weightbearing
Description: immediate weightbearing
Study: NCT04280783

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Physical Activity for The Heart (PATH) intervention
Description: The web-based Physical Activity for The Heart (PATH) intervention leverages openly accessible platforms, such as YouTube, to proffer workout videos that match the participants preferences. Currently, PATH includes over 90 workout videos vetted by a team of experts and curated on the PATH website in 3 controlled levels of intensity (beginner, intermediate, proficient) to foster gradual progression from low to high intensity PA in accordance with the FITT-VP (frequency, intensity, time, type, volume, progression) principle.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Be Active Your Way Booklet
Description: Be Active Your Way booklet was developed by the Centers for Disease Control (CDC) to help individuals integrate PA in their daily lives. It simply encourages individuals to increase their PA gradually and gives them examples of things that they can do.
Study: NCT03755401

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TFPP
Description: Trauma-Focused Psychodynamic Psychotherapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: treatment as usual at the VA for PTSD
Study: NCT03443401

Intervention type: PROCEDURE
Intervention: Standard physical therapy care
Description: standard plan of care delivered to patient with chronic low back within scope of licensure

Intervention type: PROCEDURE
Intervention: Standard physical therapy care
Description: standard plan of care delivered to patient with chronic low back within scope of licensure
Study: NCT00800345

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Topotecan
Description: Starting on Cycle 1 Day 1, each subject will receive the assigned dose of topotecan administered by mouth.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib
Description: Starting on Cycle 1 Day 1, each subject will receive the assigned dose of pazopanib administered by mouth.
Study: NCT03457662

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: OMC and pseudo-SDT
Description: OMC is established according to the 2016 ACC-AHA Guidelines for the Management of Patients with PAD. Pseudo-SDT combines saline injection and obstructed ultrasound exposure on targeted lesions to simulate real SDT progression.
Study: NCT06464874

Intervention type: PROCEDURE
Intervention: Conventional ESD
Description: Conventional ESD is the most suitable method for total resection, especially for large lesions. This method can complete the resection of early gastrointestinal cancer and precancerous lesions, while maintaining the integrity of digestive tract anatomy and physiological function.The operation difficulty of this technique is high, the equipment requirements are high, the operation time is long, and the complication rate is closely related to the technical level of the operator.
Study: NCT00332878

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stepping Stones
Description: a comprehensive sexual and reproductive health promotion programme lasting about 50 hours comprising 13 content sessions of about 3 hours duration and 4 meetings of peer groups

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: stepping Stones short
Description: 3 hour intervention on HIV and safer sex
Study: NCT03585842

Intervention type: OTHER
Intervention: No intervention
Description: No intervention

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT01925001

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium chloride solution
Description: Normal saline solution (0.9% Sodium Chloride Injection USP)
Study: NCT06464874

Intervention type: PROCEDURE
Intervention: Hybrid ESD
Description: Hybrid ESD is a better choice, but only can remove the lesion in one piece, but also has a lower technical difficulty than conventional ESD
Study: NCT05830682

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: using a walking aid
Description: The walking aid utilized for mobilizing patients in the intervention group during the study is a four-wheeled device that allows for movement in all directions. The height of the device can be adjusted according to the patients' height. It features a seat for resting when needed and a braking system that is controlled from the hand grips.
Study: NCT01817686

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Comfort Default AD forms
Description: Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Life Extension Default AD forms
Description: Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Default AD forms
Description: Consenting subjects will be randomly assigned to one of 3 study arms. Subjects will receive a different AD form based on which arm they have been randomly assigned. Once a completed AD form is received, a debriefing session will be held to alert patients to exactly how the 3 ADs used in the study differ. Once patients are fully informed about the variations in the ADs, the patients will have an opportunity to change their AD selections prior to finalizing them as a part of their medical record. A final satisfaction interview will take place with a research associate who will contact patients via telephone to administer a satisfaction questionnaire.